IONS logo

Ionis Pharmaceuticals (IONS) EBIT

annual EBIT:

-$375.71M-$117.34M(-45.42%)
December 31, 2024

Summary

  • As of today (May 29, 2025), IONS annual earnings before interest & taxes is -$375.71 million, with the most recent change of -$117.34 million (-45.42%) on December 31, 2024.
  • During the last 3 years, IONS annual EBIT has fallen by -$350.96 million (-1418.15%).
  • IONS annual EBIT is now -206.98% below its all-time high of $351.21 million, reached on December 31, 2019.

Performance

IONS EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

quarterly EBIT:

-$125.40M-$39.63M(-46.20%)
March 31, 2025

Summary

  • As of today (May 29, 2025), IONS quarterly earnings before interest & taxes is -$125.40 million, with the most recent change of -$39.63 million (-46.20%) on March 31, 2025.
  • Over the past year, IONS quarterly EBIT has dropped by -$3.23 million (-2.64%).
  • IONS quarterly EBIT is now -155.56% below its all-time high of $225.72 million, reached on December 31, 2021.

Performance

IONS quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

TTM EBIT:

-$377.45M-$3.23M(-0.86%)
March 31, 2025

Summary

  • As of today (May 29, 2025), IONS TTM earnings before interest & taxes is -$377.45 million, with the most recent change of -$3.23 million (-0.86%) on March 31, 2025.
  • Over the past year, IONS TTM EBIT has dropped by -$95.44 million (-33.84%).
  • IONS TTM EBIT is now -207.47% below its all-time high of $351.21 million, reached on December 31, 2019.

Performance

IONS TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

IONS EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-45.4%-2.6%-33.8%
3 y3 years-1418.2%-98.3%-10000.0%
5 y5 years-207.0%-143.7%-327.1%

IONS EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1418.2%at low-793.5%at low-2706.2%at low
5 y5-year-207.0%at low-155.6%at low-327.1%at low
alltimeall time-207.0%at low-155.6%at low-207.5%at low

IONS EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$125.40M(+46.2%)
-$377.45M(+0.9%)
Dec 2024
-$375.71M(+45.4%)
-$85.77M(-30.2%)
-$374.22M(+38.4%)
Sep 2024
-
-$122.87M(+183.0%)
-$270.37M(+0.9%)
Jun 2024
-
-$43.41M(-64.5%)
-$267.93M(-5.0%)
Mar 2024
-
-$122.17M(-775.6%)
-$282.02M(+9.7%)
Dec 2023
-$258.37M(+3.4%)
$18.08M(-115.0%)
-$256.97M(-18.1%)
Sep 2023
-
-$120.43M(+109.4%)
-$313.66M(+31.2%)
Jun 2023
-
-$57.50M(-40.8%)
-$239.14M(-15.7%)
Mar 2023
-
-$97.12M(+151.6%)
-$283.71M(+13.6%)
Dec 2022
-$249.86M(+909.6%)
-$38.61M(-15.9%)
-$249.84M(-1825.1%)
Sep 2022
-
-$45.91M(-55.0%)
$14.48M(-164.4%)
Jun 2022
-
-$102.08M(+61.4%)
-$22.48M(<-9900.0%)
Mar 2022
-
-$63.25M(-128.0%)
$46.00K(-100.2%)
Dec 2021
-$24.75M(-80.7%)
$225.72M(-372.4%)
-$24.94M(-90.6%)
Sep 2021
-
-$82.87M(+4.2%)
-$266.11M(+25.3%)
Jun 2021
-
-$79.55M(-9.8%)
-$212.36M(+28.0%)
Mar 2021
-
-$88.24M(+471.2%)
-$165.84M(+28.5%)
Dec 2020
-$128.35M(-136.5%)
-$15.45M(-47.0%)
-$129.06M(-237.8%)
Sep 2020
-
-$29.12M(-11.8%)
$93.68M(-32.3%)
Jun 2020
-
-$33.03M(-35.8%)
$138.32M(-16.8%)
Mar 2020
-
-$51.45M(-124.8%)
$166.22M(-52.7%)
Dec 2019
$351.21M(-1219.7%)
$207.29M(+1235.7%)
$351.21M(+111.4%)
Sep 2019
-
$15.52M(-402.1%)
$166.14M(+17.0%)
Jun 2019
-
-$5.14M(-103.8%)
$141.99M(+39.2%)
Mar 2019
-
$133.53M(+500.8%)
$102.02M(-425.3%)
Dec 2018
-$31.37M(-212.1%)
$22.22M(-357.5%)
-$31.36M(-47.0%)
Sep 2018
-
-$8.63M(-80.9%)
-$59.13M(+28.0%)
Jun 2018
-
-$45.10M(<-9900.0%)
-$46.21M(-692.1%)
Mar 2018
-
$141.00K(-102.5%)
$7.80M(-72.1%)
Dec 2017
$27.99M(-249.9%)
-$5.54M(-229.2%)
$27.99M(-71.6%)
Sep 2017
-
$4.29M(-51.8%)
$98.42M(-11.5%)
Jun 2017
-
$8.91M(-56.1%)
$111.23M(+102.8%)
Mar 2017
-
$20.33M(-68.7%)
$54.85M(-393.8%)
Dec 2016
-$18.67M(-63.5%)
$64.89M(+279.5%)
-$18.67M(-87.1%)
Sep 2016
-
$17.10M(-136.0%)
-$145.27M(-23.1%)
Jun 2016
-
-$47.46M(-10.8%)
-$188.91M(+97.0%)
Mar 2016
-
-$53.20M(-13.8%)
-$95.88M(+87.4%)
Dec 2015
-$51.17M(+59.0%)
-$61.71M(+132.5%)
-$51.17M(-252.8%)
Sep 2015
-
-$26.54M(-158.3%)
$33.49M(-15.8%)
Jun 2015
-
$45.56M(-637.0%)
$39.75M(-429.8%)
Mar 2015
-
-$8.48M(-137.0%)
-$12.05M(-62.5%)
Dec 2014
-$32.18M(-31.8%)
$22.95M(-213.2%)
-$32.18M(-56.5%)
Sep 2014
-
-$20.28M(+225.1%)
-$74.00M(-5.9%)
Jun 2014
-
-$6.24M(-78.2%)
-$78.62M(-0.3%)
Mar 2014
-
-$28.61M(+51.6%)
-$78.88M(+67.1%)
Dec 2013
-$47.20M(-11.7%)
-$18.87M(-24.2%)
-$47.20M(+36.6%)
Sep 2013
-
-$24.90M(+283.1%)
-$34.56M(-17.9%)
Jun 2013
-
-$6.50M(-312.5%)
-$42.07M(+33.3%)
Mar 2013
-
$3.06M(-149.1%)
-$31.56M(-40.9%)
Dec 2012
-$53.44M(-21.5%)
-$6.22M(-80.8%)
-$53.44M(-14.0%)
Sep 2012
-
-$32.41M(-907.8%)
-$62.14M(+19.9%)
Jun 2012
-
$4.01M(-121.3%)
-$51.84M(-26.3%)
Mar 2012
-
-$18.81M(+26.0%)
-$70.29M(+3.3%)
Dec 2011
-$68.06M(+42.0%)
-$14.93M(-32.5%)
-$68.06M(+7.0%)
Sep 2011
-
-$22.11M(+53.1%)
-$63.63M(+25.7%)
Jun 2011
-
-$14.44M(-12.9%)
-$50.63M(-12.8%)
Mar 2011
-
-$16.58M(+57.9%)
-$58.08M(+21.2%)
Dec 2010
-$47.93M(+151.0%)
-$10.50M(+15.2%)
-$47.93M(-1.6%)
Sep 2010
-
-$9.12M(-58.4%)
-$48.69M(+0.6%)
Jun 2010
-
-$21.89M(+240.9%)
-$48.42M(+78.9%)
Mar 2010
-
-$6.42M(-43.0%)
-$27.06M(+41.7%)
Dec 2009
-$19.09M(+605.3%)
-$11.26M(+27.4%)
-$19.09M(+33.0%)
Sep 2009
-
-$8.84M(+1546.7%)
-$14.36M(+667.8%)
Jun 2009
-
-$537.00K(-134.6%)
-$1.87M(-191.2%)
Mar 2009
-
$1.55M(-123.7%)
$2.05M(-175.8%)
Dec 2008
-$2.71M(-91.8%)
-$6.53M(-279.1%)
-$2.71M(-292.3%)
Sep 2008
-
$3.64M(+7.7%)
$1.41M(-82.0%)
Jun 2008
-
$3.38M(-205.5%)
$7.82M(-151.4%)
Mar 2008
-
-$3.21M(+32.8%)
-$15.22M(-53.8%)
Dec 2007
-$32.92M
-$2.41M(-124.0%)
-$32.92M(-25.9%)
DateAnnualQuarterlyTTM
Sep 2007
-
$10.06M(-151.2%)
-$44.42M(-39.2%)
Jun 2007
-
-$19.66M(-5.9%)
-$73.02M(+3.3%)
Mar 2007
-
-$20.90M(+50.2%)
-$70.68M(+7.5%)
Dec 2006
-$65.75M(+30.9%)
-$13.91M(-25.0%)
-$65.75M(+8.0%)
Sep 2006
-
-$18.54M(+7.1%)
-$60.87M(+11.0%)
Jun 2006
-
-$17.32M(+8.4%)
-$54.82M(+10.1%)
Mar 2006
-
-$15.98M(+76.9%)
-$49.78M(-0.9%)
Dec 2005
-$50.22M(-41.2%)
-$9.03M(-27.7%)
-$50.22M(-17.1%)
Sep 2005
-
-$12.49M(+1.8%)
-$60.56M(-14.0%)
Jun 2005
-
-$12.27M(-25.3%)
-$70.45M(-11.4%)
Mar 2005
-
-$16.42M(-15.2%)
-$79.51M(-6.9%)
Dec 2004
-$85.43M(+10.7%)
-$19.37M(-13.4%)
-$85.43M(-2.4%)
Sep 2004
-
-$22.38M(+4.9%)
-$87.53M(+3.9%)
Jun 2004
-
-$21.34M(-4.5%)
-$84.22M(+4.5%)
Mar 2004
-
-$22.34M(+4.0%)
-$80.60M(+4.4%)
Dec 2003
-$77.17M(+56.1%)
-$21.48M(+12.7%)
-$77.18M(+17.7%)
Sep 2003
-
-$19.07M(+7.6%)
-$65.57M(+2.4%)
Jun 2003
-
-$17.72M(-6.3%)
-$64.01M(+9.2%)
Mar 2003
-
-$18.91M(+91.6%)
-$58.63M(+18.6%)
Dec 2002
-$49.44M(+7.2%)
-$9.87M(-43.6%)
-$49.44M(+4.6%)
Sep 2002
-
-$17.51M(+41.9%)
-$47.26M(+37.1%)
Jun 2002
-
-$12.34M(+27.0%)
-$34.46M(-10.7%)
Mar 2002
-
-$9.72M(+26.3%)
-$38.59M(-16.3%)
Dec 2001
-$46.10M(+59.0%)
-$7.70M(+63.5%)
-$46.10M(-4.8%)
Sep 2001
-
-$4.71M(-71.4%)
-$48.42M(+11.3%)
Jun 2001
-
-$16.46M(-4.5%)
-$43.50M(+23.5%)
Mar 2001
-
-$17.23M(+72.1%)
-$35.22M(+21.5%)
Dec 2000
-$28.99M(-32.7%)
-$10.01M(-4960.2%)
-$28.99M(-7.9%)
Sep 2000
-
$206.00K(-102.5%)
-$31.48M(-20.9%)
Jun 2000
-
-$8.18M(-25.7%)
-$39.78M(-8.8%)
Mar 2000
-
-$11.01M(-11.9%)
-$43.61M(+1.2%)
Dec 1999
-$43.10M(+32.6%)
-$12.50M(+54.3%)
-$43.10M(+6.9%)
Sep 1999
-
-$8.10M(-32.5%)
-$40.30M(+29.6%)
Jun 1999
-
-$12.00M(+14.3%)
-$31.10M(-3.1%)
Mar 1999
-
-$10.50M(+8.2%)
-$32.10M(-1.5%)
Dec 1998
-$32.50M(+3.8%)
-$9.70M(-981.8%)
-$32.60M(-1.8%)
Sep 1998
-
$1.10M(-108.5%)
-$33.20M(-10.0%)
Jun 1998
-
-$13.00M(+18.2%)
-$36.90M(+9.8%)
Mar 1998
-
-$11.00M(+6.8%)
-$33.60M(+6.7%)
Dec 1997
-$31.30M(+7.6%)
-$10.30M(+296.2%)
-$31.50M(+2.6%)
Sep 1997
-
-$2.60M(-73.2%)
-$30.70M(-11.8%)
Jun 1997
-
-$9.70M(+9.0%)
-$34.80M(+4.8%)
Mar 1997
-
-$8.90M(-6.3%)
-$33.20M(+14.1%)
Dec 1996
-$29.10M(+13.7%)
-$9.50M(+41.8%)
-$29.10M(+12.8%)
Sep 1996
-
-$6.70M(-17.3%)
-$25.80M(-2.6%)
Jun 1996
-
-$8.10M(+68.8%)
-$26.50M(+8.6%)
Mar 1996
-
-$4.80M(-22.6%)
-$24.40M(-5.1%)
Dec 1995
-$25.60M(+13.8%)
-$6.20M(-16.2%)
-$25.70M(-16.3%)
Sep 1995
-
-$7.40M(+23.3%)
-$30.70M(+8.5%)
Jun 1995
-
-$6.00M(-1.6%)
-$28.30M(+4.4%)
Mar 1995
-
-$6.10M(-45.5%)
-$27.10M(+6.3%)
Dec 1994
-$22.50M(+23.0%)
-$11.20M(+124.0%)
-$25.50M(+36.4%)
Sep 1994
-
-$5.00M(+4.2%)
-$18.70M(+3.3%)
Jun 1994
-
-$4.80M(+6.7%)
-$18.10M(+1.1%)
Mar 1994
-
-$4.50M(+2.3%)
-$17.90M(-3.2%)
Dec 1993
-$18.30M(-15.3%)
-$4.40M(0.0%)
-$18.50M(-14.0%)
Sep 1993
-
-$4.40M(-4.3%)
-$21.50M(-2.3%)
Jun 1993
-
-$4.60M(-9.8%)
-$22.00M(+1.9%)
Mar 1993
-
-$5.10M(-31.1%)
-$21.60M(+0.5%)
Dec 1992
-$21.60M(+105.7%)
-$7.40M(+51.0%)
-$21.50M(+12.6%)
Sep 1992
-
-$4.90M(+16.7%)
-$19.10M(+15.1%)
Jun 1992
-
-$4.20M(-16.0%)
-$16.60M(+12.9%)
Mar 1992
-
-$5.00M(0.0%)
-$14.70M(+33.6%)
Dec 1991
-$10.50M(+133.3%)
-$5.00M(+108.3%)
-$11.00M(-8.3%)
Sep 1991
-
-$2.40M(+4.3%)
-$12.00M(+31.9%)
Jun 1991
-
-$2.30M(+76.9%)
-$9.10M(+44.4%)
Mar 1991
-
-$1.30M(-78.3%)
-$6.30M(+40.0%)
Dec 1990
-$4.50M
-$6.00M(-1300.0%)
-$4.50M(-400.0%)
Sep 1990
-
$500.00K(0.0%)
$1.50M(+50.0%)
Jun 1990
-
$500.00K(0.0%)
$1.00M(+100.0%)
Mar 1990
-
$500.00K
$500.00K

FAQ

  • What is Ionis Pharmaceuticals annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals annual EBIT year-on-year change?
  • What is Ionis Pharmaceuticals quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals quarterly EBIT year-on-year change?
  • What is Ionis Pharmaceuticals TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals TTM EBIT year-on-year change?

What is Ionis Pharmaceuticals annual earnings before interest & taxes?

The current annual EBIT of IONS is -$375.71M

What is the all time high annual EBIT for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high annual earnings before interest & taxes is $351.21M

What is Ionis Pharmaceuticals annual EBIT year-on-year change?

Over the past year, IONS annual earnings before interest & taxes has changed by -$117.34M (-45.42%)

What is Ionis Pharmaceuticals quarterly earnings before interest & taxes?

The current quarterly EBIT of IONS is -$125.40M

What is the all time high quarterly EBIT for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high quarterly earnings before interest & taxes is $225.72M

What is Ionis Pharmaceuticals quarterly EBIT year-on-year change?

Over the past year, IONS quarterly earnings before interest & taxes has changed by -$3.23M (-2.64%)

What is Ionis Pharmaceuticals TTM earnings before interest & taxes?

The current TTM EBIT of IONS is -$377.45M

What is the all time high TTM EBIT for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high TTM earnings before interest & taxes is $351.21M

What is Ionis Pharmaceuticals TTM EBIT year-on-year change?

Over the past year, IONS TTM earnings before interest & taxes has changed by -$95.44M (-33.84%)
On this page